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Abstract
The complex host-pathogen interplay involves the recognition of the pathogen by the host’s innate immune system and
countermeasures taken by the pathogen. Detection of invading bacteria by the host leads to rapid activation of the
transcription factor NF-kB, followed by inflammation and eradication of the intruders. In response, some pathogens,
including enteropathogenic Escherichia coli (EPEC), acquired means of blocking NF-kB activation. We show that inhibition of
NF-kB activation by EPEC involves the injection of NleE into the host cell. Importantly, we show that NleE inhibits NF-kB
activation by preventing activation of IKKb and consequently the degradation of the NF-kB inhibitor, IkB. This NleE activity is
enhanced by, but is not dependent on, a second injected effector, NleB. In conclusion, this study describes two effectors,
NleB and NleE, with no similarity to other known proteins, used by pathogens to manipulate NF-kB signaling pathways.
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Introduction
Enteropathogenic Escherichia coli (EPEC) belong to a group of
pathogens defined by their ability to form ‘‘attaching and effacing’’
(AE) histopathology on intestinal epithelia. These pathogens
employ their type III protein secretion system (TTSS) to inject
(translocate) toxic proteins (effectors) into the host cell. The
injected effectors subvert normal host cell functions to benefit the
bacteria (summarized in [1]). To date, 21 effectors or putative
effector genes have been described for EPEC. Six of them are
encoded in the LEE region that also encodes the TTSS structural
genes, whereas the other 15 effector genes are distributed within
three prophages and three insertion elements (IE) [2].
Upon infection, bacterial PAMPs (pathogen-associated mo-
lecular patterns) including LPS, flagellin, lipoproteins, and CpG
DNA stimulate host cell Toll-like receptors (TLRs) in the host
cells, leading to a formidable immune response via the activation
of the transcription factor NF-kB[ 3 , 4 ] .N F - kB comprises a
family of closely related transcription factors that play a key role
in the expression of genes involved in inflammation, immune,
and stress responses. NF-kB is a collective term used for homo-
and heterodimeric complexes formed by the Rel/NF-kB
proteins. In mammals, five of such proteins are known: RelA
(p65), RelB, c-Rel, p50 (NF-kB1), and p52 (NF-kB2). Under
nonstimulating conditions, NF-kB is retained in the cytoplasm
through its association with inhibitory proteins (IkBs). A variety
of signaling pathways activate IkB kinases (IKK) to phosphor-
ylate IkB, leading to its ubiquitination and degradation by the
proteasome. This allows translocation of NF-kBt ot h en u c l e u s ,
activation of NF-kB-regulated genes, and establishment of an
inflammatory response [5,6].
Previous reports have suggested that during infection, EPEC
manipulate NF-kB-mediated inflammation. Initially, it was shown
that EPEC activate NF-kB by a TTSS-dependent mechanism
[7,8], but later, it was reported that the TTSS is not required and
that EPEC activate NF-kB via a TTSS-independent mechanism,
presumably by activation of TLRs [9,10,11,12]. Moreover, some
reports showed that EPEC actually repress NF-kB activation by a
TTSS-dependent mechanism [13,14]. Taken together, these
reports suggest that EPEC first elicit NF-kB activation by a
TTSS-independent mechanism and subsequently, it utilize the
TTSS mechanism to mediate TTSS-dependent NF-kB-repression.
However, the major gap in the above hypothesis is that the
putative effector that presumably represses NF-kB activation has
never been identified. In this report we confirm that EPEC block
NF-kB activation via a TTSS-dependent mechanism and show
that the NleE effector is necessary and sufficient to block NF-kB
activation via inhibition of IkB phosphorylation and thus induces
its stabilization. In addition, we show that a second effector, NleB,
is required for better repression of NF-kB activation, suggesting
that the function of NleB is related to that of NleE.
Results
EPEC inhibit IkB degradation and NF-kB activation by a
TTSS-dependent mechanism
The ability of EPEC to either inhibit or induce NF-kB
activation is controversial. Therefore, we re-examined this point
PLoS Pathogens | www.plospathogens.org 1 January 2010 | Volume 6 | Issue 1 | e1000743using HeLa cells as host cells and IkB stability as a read-out for
NF-kB activation. Importantly, TNFa treatment strongly stimu-
lates IkB degradation in these cells, but under the used
experimental conditions they exhibited minimal IkB degradation
upon exposure to the PAMPs of the infecting EPEC. This allowed
the uncoupling of infection and NF-kB activation. HeLa cells were
infected with EPEC culture for 3 h, during which the bacteria
injected the TTSS effectors into host cells. The infected cells were
then treated with 10 ng/ml TNFa to activate NF-kB and at
different time points post TNFa-induction, cellular lysates were
subjected to western analysis. The results show that TNFa
treatment induced rapid degradation of IkB in uninfected cells
or cells infected with EPEC TTSS-deficient mutant (escN::kan). In
contrast, IkB in cells infected with wild-type EPEC remained
stable (Fig. 1A).
We next tested whether the stabilization of IkBb yE P E C
was associated with inhibition of NF-kB translocation to the
nucleus. To monitor NF-kB activation, we used a reporter cell
line (AGS SIB02) stably expressing the NF-kB subunit p65
fused to GFP. Cells were infected with wild-type EPEC or, as
a negative control, with EPEC TTSS mutant (escV::kan). After
3 h of infection, cells were washed, induced with TNFa,a n d
at 15, 45, 60, and 75 min post TNFa-induction, the cells were
fixed, stained with Hoechst 33342, and analyzed by automat-
ed microscopy. Importantly, whereas wild-type EPEC re-
pressed p65-GFP translocation to the nucleus, the TTSS escV
mutant was strongly attenuated in this activity (Fig. 1B). To
validate the above microscopic analysis we carried out
identical experiment, but instead of using microscopy to
analyze the cells we fractionated the cells into cytoplasmic and
nucleus fractions and determined the amount of p65 in the
different fractions by immunoblot using anti-p65 antibody.
The results were in agreement with the microscopic analysis:
wild type EPEC, but not the escV mutant, blocked transloca-
tion of p65 to the nucleus (Fig. 1C). Thus supporting the
notion that EPEC inhibit NF-kB activation by a TTSS-
dependent mechanism [13,14], and suggesting that EPEC
deliver into infected cells one or more effectors that inhibits
NF-kB activation.
NleH has been proposed as such an effector since it is similar to
OspG, a Shigella effector that inhibits NF-kB activation [15].
However, we found that an EPEC strain, in which both nleH
alleles were deleted, still inhibited IkB degradation, similarly to
wild-type EPEC (Fig. 1D), suggesting that NleH is not required for
blocking IkB degradation under the experimental conditions used
by us.
Author Summary
The innate immune system senses intruding pathogens and
in response, mounts an inflammatory reaction. Essential for
this response is the activation of the transcription factor NF-
kB, which mediates reprogramming of gene expression in
the host. The bacteria Escherichia coli is usually a non-
pathogenic resident of our intestinal track. Some E. coli
strains, however, cause disease or food poisoning; one of
these pathogenic strains is enteropathogenic E. coli (EPEC).
This pathogen employs a syringe-like organelle, termed
type three secretion system (TTSS), to inject into the
intestinal host cell a battery of toxic proteins termed
effectors. We found that two of the effectors that EPEC
injects into the host cell upon infection block the activation
of NF-kB and thus interfere with the host immune response.
Thesefindings elucidate the intricatecross-talk betweenthe
host immune system and the pathogen.
Figure 1. EPEC inhibit TNFa-induced IkB degradation and NF-kB translocation to the nucleus in a TTSS-dependent manner. (A) HeLa
cells were infected with wild-type EPEC (WT), a TTSS mutant (escN::kan) or remained uninfected (N/I). After 3h, cells were washed and treated with
10 ng/ml TNFa. At the indicated time post TNFa treatment, cells were extracted and subjected to western blot analysis with anti-IkB antibodies and
anti-tubulin (loading control). (B) AGS SIB02 cells expressing p65-GFP were infected with wild-type EPEC or with a EPEC TTSS mutant (escV::kan)o r
remained uninfected. After 3 h, the cells were washed and treated with TNFa. At the indicated time post TNFa treatment, cells were fixed, nuclei
stained, and the levels of p65-GFP translocation in ,200 cells were analyzed by automated microscopy and image analysis software. Standard errors
are indicated by bars. (C) HeLa cells were infected with different strains and treated with TNFa as described for (B). At 30 min post TNFa induction,
cells were harvested and fractionated into nuclear and cytoplasmic fractions. The presence of the p65 in the different fractions was analyzed by
Western blot using anti-p65 antibody. (D) IkB degradation assay was conducted (as described for A) using uninfected cells, cells infected with EPEC
wild-type strain and with an EPEC mutant deleted of its two nleH alleles (nleH mutant).
doi:10.1371/journal.ppat.1000743.g001
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To identify putative effector(s) that block IkB degradation, we
bioinformaticly compared the genome of EPEC to that of non-
pathogenic E. coli K12 and identified large EPEC-specific regions
that contain, or possibly contain, effector genes. Based on this
comparison, we constructed a set of 15 EPEC strains, each deleted
of one EPEC-specific large chromosomal region (Table 1).
Altogether, 770 EPEC-specific ORFs were deleted. We then tested
the capacity of each of the deleted strainsto inhibitIkB degradation
upon TNFa treatment. One of the strains, deleted of the IE6 region
[2], could not inhibit IkB degradation (data not shown). Further
systematic deletion analysis defined two effector-encoding genes,
nleB and nleE, required for stabilizing IkB (Fig. 2A, 2B and data not
shown). Deletion of nleE strongly reduced the bacteria’s capacity to
stabilize IkB, but a complete deficiency in IkB stabilization was
observed only in the strain deleted of both nleB and nleE (Fig. 2B).
To corroborate the notion that NleE is required for IkB
stabilization, we complemented a strain deleted of the nleBE region
with plasmids containing nleB, nleE,o rnleBE. We found that
expression of NleE, but not of NleB, partially restored EPEC’s
capacity to stabilize IkB (Fig. 2C). Importantly, full IkB protection
was achieved in strains expressing both NleB and NleE (Fig. 2C). A
mutant expressing only NleB showed only low level of IkB
protection (Fig. 2C). Taken together, these results suggest that NleB
and NleE, located at the IE6 region, are necessary for stabilizing
IkB and that this activity is contributed mainly by NleE (Fig. 2B).
We therefore focused our attention on NleE.
NleEIE2 is not required for IkB stabilization
EPEC encode two very similar nleE alleles. One allele, identified
in our screen, is located in the IE6 region and the other is in the
IE2 region [2]. We initially found that deletion of the IE6 region,
but not of the IE2 region, caused deficiency in inhibition of IkB
degradation (data not shown). However, the two proteins, NleEIE2
and NleEIE6, are identical, apart from an internal deletion of 56
residues in NleEIE2 (Fig. S1), and this similarity between the two
proteins urged us to determine the activity of each of the two
proteins. We first tested their ability to complement IkB
destabilization in a strain deleted of nleEIE6. To this end, we
expressed each of them on a plasmid carrying an identical
promoter and ribosomal binding site. Results showed that only
NleEIE6, but not NleEIE2, was able to attenuate IkB degradation
(Fig. 3A). These results indicate that NleEIE2 is either not active in
the host cell or is not translocated into the host cell. To
differentiate between these two possibilities, we used the above
mentioned plasmid where both proteins were fused to the b-
lactamase translocation reporter protein, BlaM. The plasmids
were introduced into EPEC and the ability to translocate them
into infected cells was tested. We found that both NleEIE2-BlaM
and NleEIE6-BlaM were expressed at similar levels in the bacteria
(Fig. 3B). Importantly, however, only NleEIE6 was translocated
into the host cell (Fig. 3C), suggesting that NleEIE2 is a cryptic
effector. Cumulatively, these results define NleEIE6, but not
NleEIE2, as the effector needed for inhibition of IkB degradation.
Therefore, in this report the term ‘‘NleE’’ specifically refers to
‘‘NleEIE6’’.
NleE is required for complete inhibition of NF-kB
translocation to the nucleus
To corroborate the notion that NleE is required for inhibition of
NF-kB activation, we examined whether the nleE mutant is
deficient in blocking the translocation of the p65 NF-kB subunit to
the nucleus upon TNFa treatment. Because of the high similarity
between the IE2 region and the IE6 region, we made the specific
mutants (DnleEIE6, DnleEBIE6) in a strain deleted of its IE2 region
(DIE2). Therefore, these specific strains were compared to their
parental strain (indicated as WTDIE2 in the figures). It should be
emphasized that the DIE2 mutant exhibited the wild-type
phenotype in all the assays used in this study.
AGS SIB02 cells expressing p65-GFP were infected with the
parental strain WTDIE2 or with the corresponding mutants:
DescV, DnleE, DnleBE,a n dDnleE complemented with a plasmid
Table 1. List of the deletions of large EPEC chromosomal islands.
Strain Name Island Name
a Size in Kb Location Number of Putative ORFs Notes
b
EM3321 6M (PP2) 53.7 720891..774629 84 Contains nleHpp2, espJ,a n dacif pseudogene
EM3323 7M 34.3 855103..889419 61
EM3325 8M (PP4) 45 1046278..1091304 68 Contains nleG/, nleBpp4, nleC,a nnleH fragment, and nleD
EM3327 9M (IE2) 61.2 1121572..1182762 60 Contains lifA/efa1IE2, nleEIE2, nleBIE2, and an espL pseudogene
EM3329 10M 40.6 1270890..1311501 50
EM3331 13M (PP6) 55.6 1430190..1485767 61 Contains nleHpp6, nleA/espI, nleF, and an espO fragment
EM3333 17M 36.4 1869528..1905895 55
EM3335 18Ma 26.4 2149581..2175998 30
EM3337 18Mb 18 2183694..2201688 30
EM3339 21M 47.8 2590597..2638364 71
EM3341 22M 36.6 2718268..2754895 55
EM3343 24M 58.9 2814904..2873848 72
EM3345 26M (IE5) 15.2 3001568..3016789 13 Contains espG2 and espC
EM3347 29M (IE6) 29.6 3341269..3370924 23 Contains lifA/efa1IE6, nleEIE6, nleBIE6, and espLIE6
EM3349 48M 27.4 4850071..4877448 37
Total 586.7 770
a–The Islands’ nomenclature used by Iguchi et al. [2] is in brackets.
b–Based on Iguchi et al. [2].
doi:10.1371/journal.ppat.1000743.t001
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stained with Hoechst 33342 and analyzed by automated
microscopy. The results show that whereas the wild type
repressed ,90% of the p65 translocation to the nucleus, the
TTSS escV mutant was attenuated, exhibiting only ,50%
repression (Fig. 4A). These results indicate that EPEC inhibit
p65 translocation by both TTSS-independent and TTSS-
dependent pathways. Importantly, the nleE and nleBE mutants
were as deficient as the escV mutant in blocking p65
translocation. Moreover, complementation of the nleE mutant
with the wild-type nleE allele restored the bacteria’s full capacity
to inhibit the p65 translocation ( F i g .4 A ) .T h e s er e s u l t ss u p p o r t
the hypothesis that the TTSS-mediated inhibition of p65
translocation is NleE-dependent. In addition, our results suggest
that a putative TTSS-independent mechanism might function in
parallel to NleE to inhibit p65 translocation.
NleE is required for full inhibition of TNFa-induced IL-8
expression
To further substantiate our results, we used IL-8 expression as
an additional read-out for NF-kB activation. Briefly, HeLa cells
were infected with different EPEC strains or remained uninfected.
Then, cells were washed and treated for 3 h with TNFa and
gentamycin, to kill the remaining bacteria. RNA was then
extracted from the cells and the amount of produced IL-8 mRNA
was measured by real time PCR. In comparison to non infected
cells or cells infected with EPEC escV mutant, both wild type and
the DIE2 mutant exhibit a ,100 fold repression of IL8 expression
(Fig. 4B). In contrast, the nleE mutant exhibited a partial, less then
10 fold, repression of IL8 expression and this was moderately
complemented by plasmid expressing native NleE (Fig. 4B). A
more severe deficiency in repression of IL8 expression was
exhibited by a double mutant nleBE (Fig. S3). Furthermore, a
plasmid expressing nleBE restored IL8 repression to that seen in
wild type EPEC (Fig. S3). Upon testing the amount of secreted IL8
protein instead of production of IL8 mRNA, similar results were
obtained (Fig. S2). Taken together these results show that (i) NleE
is required for full inhibition of IL-8 expression, (ii) NleB also
contributes to this repression and iii) a putative TTSS effector(s),
other then NleB and NleE might function in parallel to inhibit IL-
8 expression.
Figure 2. NleE is required for EPEC inhibition of TNFa-induced
IkB degradation. (A) Schematic of the region within IE6 containing
the nleBE genes and the chromosomal deletions used for the analysis.
Black lines represent the chromosomal DNA and gray dashed lines
represent the deleted regions. The corresponding names of the deleted
strains are indicated on the right side. (B) HeLa cells were either
uninfected (N/I) or infected with wild-type EPEC (WT) or with the
different mutants shown in (A), as indicated. After 3h, cells were
washed, treated with TNFa for 40 min and extracted. The extracts were
analyzed by western blot with anti-IkB and anti-tubulin (loading
control) antibodies. (C) HeLa cells were infected with a strain (SC3518)
carrying a chromosomal deletion of the nleBE region, which was
complemented or not complemented with plasmids expressing nleB,
nleE,o rnleBE (indicated as B, E, and BE, respectively). After 3h, cells were
washed, treated with TNFa for 30 min. and extracted. The extracts were
analyzed by western blot using anti-IkB and anti-tubulin antibodies.
doi:10.1371/journal.ppat.1000743.g002
Figure 3. NleE of IE2 is deficient in translocation and inhibition
of IkB degradation. (A) HeLa cells were either uninfected (N/I) or
infected with a strain deleted of nleEIE6 (SC3680) (see Fig. 2A),
complemented or not complemented with plasmids expressing NleEIE2
or NleEIE6 (indicated as E2 and E6, respectively). After 3h, cells were
washed, treated with TNFa for 30 min and extracted. The extracts were
analyzed by western blot with anti-IkB and anti-tubulin antibodies. (B
and C) HeLa cells were infected with wild-type EPEC harboring plasmids
expressing nleEIE2 or nleEIE6 fused to the blaM reporter gene (indicated
as pnleE2 and pnleE6, respectively). As a negative control, cells were
infected with EPEC harboring the parental vector pCX341 (Vector). The
b-lactamase activity in the infecting bacteria, reflecting the expression
levels of the fusion proteins (B), and the b-lactamase activity in the
infected HeLa cells, reflecting the levels of translocation of the fusion
proteins into the HeLa cells (C) were determined. The experiment was
done twice in triplicates and typical results are shown. Standard errors
are indicated by bars.
doi:10.1371/journal.ppat.1000743.g003
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The IL8 expression assay was found to be much more sensitive
then testing translocation to the nucleus or the IkB degradation
assay. This is probably since the latter are very transient events
while the mRNA tends to accumulate, increasing the signal/noise
ratio. Interestingly, using the IL8 expression assay we found that
infection with the escV mutant was sufficient to induce IL8
expression in HeLa cells, albeit not as strong as that induced by
TNFa (data not shown). This activation is possibly via the activity
of flagellin, LPS or other PAMPs. We thus next asked whether
NleE also inhibits the EPEC-induced IL8 expression. To this end
we repeated the experiment described in Fig. 4B, but TNFa was
omitted. We found that even the non infected cells produce certain
levels of IL8 mRNA, but upon infection with EPEC escV mutant
we observed a ,10 fold increase in IL8 expression (Fig. 4C). In
contrast, the EPEC wild type (or the DIE2 mutant) exhibited
strong repression of the EPEC-induced IL8 expression. Impor-
tantly, the nleE mutant exhibited only a partial capacity to repress
the self-induced IL8 expression. Similar results where observed
when we used the double mutant nleBE instead of nleE mutant (Fig.
S3). However, both the nleE or the nleBE, mutants were not as
deficient in IL8 repression as the escV mutant (Fig. 4C and S3).
Thus, we predict that additional putative effector might function
in parallel to NleB and NleE to repress IL8 expression. In
conclusion, our results clearly show that i) EPEC mediate a TTSS-
dependent repression of self-induced IL8 expression; and ii) NleE
is required for full repression of the EPEC-induced IL8 expression.
NleE, expressed by HeLa cells, inhibits NF-kB
translocation to the nucleus
We next examined whether NleE is sufficient for inhibition of
NF-kB activation in the absence of the infecting bacteria and other
putative effectors. To this end, we constructed a vector expressing
mCherry fused to NleE (mCherry-NleE) and used it for transient
transfection of HeLa cells. Untransfected cells (Fig. 5A) or cells
transfected with either the mCherry-NleE vector or a vector
expressing mCherry alone (Fig. 5B) were stimulated with TNFa
for 1 h, or remained untreated. Next, these cells were fixed,
stained with anti-p65 antibody, and analyzed by fluorescent
microscopy to determine both the ability of the transiently
expressed NleE to inhibit TNFa-induced migration of p65 to
the nucleus and to determine its localization in the expressing cells.
The TNF treatment induced strong migration of p65 to the
nucleus in the untransfected cells (Fig. 5A), and in cells transfected
with the negative control vector (Fig. 5B two upper panels and
5C). Importantly, the transiently expressed mCherry-NleE in-
duced a strong inhibition of p65 translocation to the nucleus
(Fig. 5B two lower panels and 5C). The expressed mCherry and
mCherry-NleE were similarly distributed in the cells, predomi-
nantly in the cytoplasm (Fig. 5B). These results indicate that
NleEIE6 is sufficient for inhibition of NF-kB migration to the
nucleus presumably by IkB stabilization. Similar analysis using
NleEIE2 instead of NleEIE6, show that NleEIE2 lost the ability to
block p65 translocation to the nucleus (Fig. S4), highlighting the
importance for NleE activity of the region between residues 49–
115, which is deleted in NleEIE2 (Fig. S1).
NleE inhibits phosphorylation of IkB
Different NF-kB activating pathways converge at the level of
IKK phosphorylation, which subsequently leads to IkB phosphor-
ylation, targeting it to ubiquitination and proteasome-mediated
degradation [6]. We thus tested whether NleE inhibits the TNFa-
induced IkB phosphorylation. Cells were infected with different
EPEC strains followed by TNFa treatment. The levels of IkB and
phospho-IkB were then determined by immunoblot analysis with
the appropriate antibodies and the relative accumulation of
unphosphorylated IkB was determined. For a negative control, we
used cells infected with the escN mutant, which cannot stabilize IkB
(Fig. 1A). Indeed, in cells infected with this mutant we noted
increased IkB phosphorylation followed by its degradation.
However, the addition of proteasome inhibitor (MG132) resulted
in accumulation of phosphorylated IkB (Fig. 6A). As a parental
strain, we used the DIE2 strain (WTDIE2), which, like wild-type
EPEC, efficiently protected IkB from degradation (Fig. 1A and
Figure 4. NleE is required to block IL-8 secretion by EPEC. AGS
SIB02 cells expressing p65-GFP (A) or HeLa cells (B and C) were infected
with the parental strain deleted of the IE2 region (strain EM3327,
indicated as WTDIE2) or with several isognic mutants including a mutant
deleted of nleE (strain SC3908, indicated as DnleE), a mutant deleted of
nleBE (strain SC3909, indicated as DnleBE) and a mutant deleted of nleE
and complemented with a plasmid expressing nleE (pSC3982), indicated
as DnleE/pE. As positive and negative controls we used cells, which
were either uninfected (N/I) or infected with wild type EPEC (WT) or
with a TTSS mutant (strain SN1961, indicated as DescV). (A) After 3 h
infection, the cells were washed, stimulated with TNFa for 30 min, fixed,
and nuclei stained with Hoechst 33342. Nuclear translocation of p65-
GFP was quantified by automated microscopy and image analysis
software. NleE expression was induced with IPTG (0.01mM). Standard
errors are indicated by bars (n=200). (B and C) After 3 h infection, cells
were washed and treated (B), or not (C), with TNFa to induce NF-kB and
with gentamicin to kill the bacteria. After additional 3 h incubation the
cells were harvested and RNA was extracted and analyzed for the
amount of IL-8 transcripts. The amount of IL-8 mRNA in each strain is
shown as a percentage of the level relatively to the transcript levels in
the DescV mutant. The experiment was done twice in duplicates and
typical results are shown. Bars indicate standard errors.
doi:10.1371/journal.ppat.1000743.g004
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unphosphorylated. In contrast, the corresponding nleE mutant
failed to induce accumulation of unphosphorylated IkB, exhibiting
a phenotype similar to that of the escN mutant (Fig. 6A). Taken
together, these results indicate that wild-type EPEC stabilizes IkB
by preventing its phosphorylation and that NleE is required for
this activity. Indeed, complementing the DnleE mutant with a
plasmid expressing NleE restored the bacteria’s capacity to induce
the accumulation of unphosphorylated IkB (Fig. 6A).
These results suggest that one can restore the inability of the
DnleE mutant to prevent IkB degradation by two alternative
approaches: (i) by treatment with proteosome inhibition, to inhibit
phospho-IkB degradation, or (ii) by complementation with a
plasmid expressing nleE, to block IkB phosphorylation. To
compare the efficiency of these two treatments, we infected HeLa
cells with the DIE2 strain (WTDIE2), DnleE mutant, or with the
DnleE mutant complemented either by proteosome inhibitor
(MG132) treatment upon TNFa induction, or by a plasmid
expressing nleE. The results show that both treatments similarly
stabilized the IkB. However, the first treatment led to a strong
phosphorylation of the accumulated IkB whereas when NleE was
added, the accumulated IkB remained unphosphorylated (Fig. 6B).
These results further support the notion that NleE stabilizes IkB
by inhibiting its phosphorylation.
NleE inhibits IKKb activation induced by TNFa or IL1b
The signaling pathways induced by the TNF receptor (TNFR) is
different from that induced by the IL1 or TLR receptors, but both
converge at the level of IKK activation by TAK1 (Fig. 6C, [16]).
The inhibition of the self-induced IL8 expression by NleE (Fig. 4C),
is hinting that NleE functions downstream to the pathways
converging point. To directly test this prediction we tested whether
EPEC is capable of inhibiting IL1b-induced degradation of IkB.
Importantly, we found that wild type EPEC, but not the nleE
mutant, inhibited the IL1b-induced IkB degradation (Fig. 6D).
These results confirmed that NleE functions downstream to the
signaling converging point. We next tested whether NleE can
block the phosphorylation and thus activation of IKKb. To this
end we extracted proteins from cells, which were infected with
different strains and then treated with TNFa or IL1b as indicated
(Fig. 6E). The extracted proteins were subjected to western
analysis using anti-IKKb, anti-phospho-IKK, anti-IkB and anti-
Figure 5. NleE is sufficient to block translocation of NF-kB to the nucleus. (A) HeLa cells were treated with TNFa for 1 h, or remained
untreated, after which they were fixed and stained with anti-p65 (green) (bar represents 20 mm). (B) HeLa cells transfected with plasmid expressing
mCherry or mCherry-NleE (red) were treated with TNFa for 1 hr, or remained untreated, after which they were fixed and stained with anti-p65 (green).
Yellow arrows indicate cells exhibiting p65 translocation to the nucleus and white arrows indicate cells where the p65 remained cytoplasmic (bar
represents 20 mm). (C) To quantify the results shown in (B), the percentage of red cells (expressing mCherry or mCherry-NleE) containing nuclear p65
was determined. The number of cells quantified is indicated and standard errors are indicated by bars.
doi:10.1371/journal.ppat.1000743.g005
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either TNFa or IL1b induced IkB and IKK phosphorylation in
non infected cells or cells infected with the escV mutant. We also
found that wild type EPEC, but not the nleE mutant, inhibited this
IKK phosphorylation. The same inhibition is noted for the IkB
phosphorylation, in the wildtype strain, However, due to IkB
Figure 6. NleE inhibits IkBa n dI K K b phosphorylation. (A, B) HeLa cells were infected for 3 h with different EPEC strains, as indicated
followed by TNFa treatment in the absence or presence of proteasome inhibitor (MG132) or IPTG (0.01 mM) as indicated. Proteins were
extracted at 0, 20, and 40 min post TNFa treatment. The blots were developed with anti-IkB( I kB), anti-phospho IkB( P - I kB), or anti-tubulin
antibodies (loading control). The strains useda r ei n d i c a t e da b o v et h el a n e s .T h ep a r e n t a ls t rain deleted of the IE2 region, strain EM3327 is
indicated as WTDIE2. The band-densities of IkBa n dP - I kBa t4 0m i np o s tT N F a treatment were measured and the relative amounts of the
unphosphorylated IkB were calculated (indicated as ‘‘unphos. IkB[ ,%]’’) and shown below the corresponding lanes. (B) HeLa cells were infected
as in (A) and proteins were extracted at 40 min post TNFa treatment. The blots were developed and the ,% unphos. IkB was determined as in
(A). (C) Schematic of the signaling pathways initiated upon activation of the TNF and IL1 receptors (TNF-R and IL1-R, respectively). (D and E)
HeLa cells were infected with different strains as indicated or not (N/I) and treated with TNFa or IL1b as indicated. Proteins were then extracted
and the levels of IkB (D and E), phospho-IkB( P - I kB), IKKb and phospho-IKKb (P-IKK) (E), were determined by immunoblot analysis with anti-IkB,
anti-IKKb and anti-phospho-IKK respectively.
doi:10.1371/journal.ppat.1000743.g006
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cannot be seen (Fig. 6E). Complementation with plasmid
expressing wild type nleE allele only partially, but consistently
restored the inhibition of IKKb phosphorylation (Fig. 6E). These
results suggest that NleE block activation of IKKb. Taken together
our results indicate that NleE blocks the NF-kB signaling cascade
downstream to the converging point of the TNFa and IL1b
signaling pathways, but upstream to IkB phosphorylation, possibly
by direct blocking TAK1 or IKKb activation.
Discussion
In this report we showed that NleE of EPEC stabilizes the NF-
kB inhibitor, IkB, via inhibition of its phosphorylation, thereby
preventing NF-kB signaling. This activity of NleE was discovered
using an unbiased screen of EPEC strains deleted of most of the
EPEC-specific genes. We showed that an nleE mutant is deficient
in blocking IkB phosphorylation and in preventing its degradation.
Moreover, an nleE mutant was attenuated in blocking TNFa-
induced NF-kB migration to the nucleus as well as in IL-8
expression and secretion. These abilities were restored to the
mutant upon complementation with a plasmid expressing the wild-
type nleE allele. Importantly, we showed that NleE expressed in
HeLa cells blocks NF-kB translocation to the nucleus upon TNFa
treatment. Taken together, our findings indicate that NleE is
sufficient to inhibit NF-kB signaling by blocking IkB phosphor-
ylation. Further analysis suggest that NleE blocks the NF-kB
signaling cascade downstream to the converging point of the
TNFa and IL1b signaling pathways, but upstream to IkB
phosphorylation, possibly by directly blocking TAK1 or IKKb
activation.
We also show that NleB enhances NleE activity. The nleE
mutant still showed residual inhibition of IkB degradation, which
was eliminated upon further deletion of nleB. Moreover,
complementation of the nleBE double mutant with a plasmid
expressing nleBE was more efficient than a plasmid expressing only
nleE. These results suggest that NleB plays a role in IkB
stabilization. Similar results were obtained when expression of
IL8 was used as a readout for inhibition of the NF-kB signaling.
The mechanism underlying NleB function is not yet apparent.
Nevertheless, the notion that NleB and NleE function together is
supported by the facts that nleE form a putative bicistronic operon
with nleB and that nleE is consistently associated with nleB in
natural isolates of diarrheagenic EPEC [17]. Other isolates of
EPEC, EHEC, and C. rodentium carry nleB and nleE alleles almost
identical to nleBEIE6 investigated in this study (Supplemental
material Fig. S1). We predict that all NleBE proteins function
similarly.
The phenomenon of effectors functioning in parallel is common
in EPEC [1]. Interestingly, the TTSS mutants (escV) and DnleBE
were only partially deficient in blocking the TNFa-induced
migration of NF-kB to the nucleus, suggesting that an additional
TTSS-independent mechanism might function in parallel to
NleBE to inhibit translocation of NF-kB to the nucleus (Fig. 7).
This activity might be related to damping of the signal due to
continuous exposure to PAMPs like flagellin or LPS. Interestingly,
the TTSS escV mutant was completely deficient in inhibition of
IL8 expression, while the nleBE mutant was only partially deficient
in this function. We therefore predict that EPEC encode
additional putative effector(s) that function in parallel to NleBE
by blocking IL-8 expression (Fig. 7).
Where as in this study we showed that NleE represses NF-kB
activation, a recent report suggested exactly the opposite, i.e. NleE
and OspZ, an NleE-homolog encoded by Shigella, activates NF-kB
signaling [18]. The discrepancy between the two studies might
result from the use of different cell lines. In their study, Zurawski
et al. [18] used cell lines that activate NF-kB upon sensing of either
TNFa or bacterial PAMPs including LPS. The latter might
complicate the interpretation of the results. To avoid such
complications, we used in this study HeLa and AGS cells, which
are inert to LPS. Moreover, we adjusted the experimental
conditions used in this study, so that the NF-kB activation by
other bacterial PAMPs was insignificant. This facilitated the
uncoupling of effector injection and NF-kB activation, which
occurred only upon addition of TNFa. An alternative, although
less likely explanation for the inconsistency between the two
studies is that NleE functions differently in different types of cell or
different cell lines.
Like EPEC, Yersinia also employs an injected effector, YopJ, to
block IkB phosphorylation. YopJ is an acetyl transferase that
acetylates critical IKKb residues and thus prevents its activation
[19]. Although both NleE and YopJ block IKKb phosphorylation,
they are very different in sequence, which probably reflects
functional differences. We are currently investigating the NleE’s
mode of action. Other effectors that interfere with NF-kB function
include the Salmonella SspH, and Shigella IpaH9.8, which are
targeted to the host cell nucleus and inhibit NF-kB-dependent
transcription [20]. Shigella also uses OspG, which inhibits
ubiquitination of phospho-IkB [15]. Interestingly, EPEC encode
an OspG homolog, NleH. However, we found that an EPEC
strain, mutated in its two nleH alleles, still inhibit IkB degradation.
Yet, our analysis indicates that additional TTSS effector(s) inhibits
NF-kB signaling (Fig. 7) and we can not exclude the possibility that
this putative effector is nleH.
Figure 7. Schematic of inhibition of NF-kB signaling by EPEC.
Signals (indicated as lightning) sensed by different receptors elicit signal
transduction cascades that converge at the level of TAK1 activation and
IKK phosphorylation, which subsequently leads to IkB phosphorylation.
This step is inhibited by NleBE. NleE inhibits IKKb phosphorylation, but
the exact target of NleE and NleB is yet to be defined. The
phosphorylated IkB is subjected to ubiquitination and proteasome-
mediated degradation, allowing NF-kB translocation to the nucleus and
activation of expression of target genes including IL-8. Our results
predicate that in addition to NleBE, a putative non-TTSS factor and a
putative TTSS effector might inhibit NF-kB translocation to the nucleus
and IL-8 expression, respectively (Fig. 4).
doi:10.1371/journal.ppat.1000743.g007
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animal model is not yet available, but it was tested with C.
rodentium. Importantly, NleE was found to be required for full
virulence of C. rodentium upon infection of wild-type mice, but this
requirement was diminished upon infection of mice deficient in
TLR4 [21,22]. Our results revealed the rationale behind this
intriguing phenomenon. We argue that NleE-mediated NF-kB
repression is no longer needed if the host itself is deficient in
TLR4/LPS-induced NF-kB signaling.
In conclusion, we show that NleE blocks IkB phosphorylation
by IKK and thus it inhibits NF-kB signaling. We also show that
NleB enhances NleE’s activity and that EPEC probably use
additional mechanisms to interfere with other constituents of the
NF-kB signaling pathway. This is presumed to have multiple
consequences on the course of EPEC infection and the maturation
of both innate and adaptive host immune response.
Materials and Methods
Bacterial strains, plasmids, and primers
Bacterial strains, plasmids, and primers used in this study are
listed in Table S1, S2, and S3, respectively (Supplemental
material). Deletions in the EPEC chromosome were constructed
using the primers listed in Table S3, as described [23]. For
bacterial expression, the genes were cloned in the pSA10
expression vector as described [24]. In most cases the leakiness
of the Tac promotor was enough for gene expression. When
indicated, IPTG (0.01mM) was added. For the cloning procedure,
genes were amplified by RCR using the primers listed in Table S3.
Formation of plasmid-borne nleE-blaM fusions were carried out as
described [25] using the plasmid pCX341 and primers as listed in
Table S3. The nleEIE2 DNA was amplified from EPEC DIE6
mutant and that of nleEIE6 from EPEC DIE2 mutant. For
formation of mCherry fusions, the EGFP gene of pEGFP-N1
(Clonetech) was excised from the plasmid using the NotI and
BamHI and replaced by mCherry taken from pREST-mCherry,
resulting in pMS2841. This plasmid was transformed into
pSC4141 by introduction of a unique scaI site at the mCherry
39, eliminating its stop codon in the process. This was done using
QuikChange site-directed mutagenesis kit (Stratagene #200518-5)
and primers listed at Table S3. This plasmid was further used to
create the transcriptional fusion: mCherry-nleEIE6-6his (pSC4144)
and mCherry-nleEIE2-6his (pSC4350), using primers listed at Table
S3.
Analysis of IkB stability and IkB and IKKb
phosphorylation
HeLa cells (9610
5) in 4 cm plates were infected with a 1:100
dilution in DMEM of bacteria grown overnight statically at 37uC
(multiplicity of infection, MOI,1:100). Following 3 h infection in
5% CO2, at 37uC, the medium was replaced with fresh DMEM
with or without either 10 ng/ml TNFa for 40 min (or 20 ng/ml
IL-1b for 20 mins). When indicated, the infecting bacteria were
supplemented with 0.01 mM IPTG at 1.5 h post inoculation. To
terminate the infection, cells were washed with 3 ml of cold TBS
(20 mM Tris-HCl, pH 7.4, 150 mM NaCl), scraped with 1 ml of
cold TBS, collected and centrifuged, (800g, 2 min at 4uC). The
pellet was resuspended in 40 ml lysis buffer (0.5% Triton-6100,
20mM Tris-HCl pH 7.2, 0.2 mM VO4, 10 mM NaF, 30 mlo f
complete inhibitor Roche) and centrifuged (20,000g, 3 min at
4uC). Supernatant was either transferred for protein quantification
assay (BCA assay) or to a tube with loading dye (LDS sample
buffer, NuPAGE), boiled for 10 min, and then centrifuged
(20,000g, 3 min). Samples were quantified using bicinchoninic
acid (BCA) and copper sulfate. Equal protein concentration for
each sample was then loaded on SDS-PAGE gel, transferred to
PVDF membrane, and reacted with antibodies against IkB
(1:1000), Tubulin, as a loading verification control (1:2500), or
phospho-IkB (1:1000, Cell Signaling). When indicated, 20 mM
MG132 (1:1000) was used. Protein band density was quantified
using Tina software (version 2.09) and the percentage of the
unphosphorylated IkB was determined by calculating the relative
phosphorylated IkB out of the total IkB shown for each lane.
IKKb analysis was done as described for IkB except that induction
time with TNFa was reduced to 10 min and with IL1b it
remained 20 min. IKK detection was preformed by western blot
analysis using anti-IKKb antibody (1:1000, Cell Signaling
Technology, #2684) and Phospho-IKKa (Ser180)/IKKb
(Ser181) antibody (1:1000, Cell Signaling Technology, #2681S)
Analysis of p65 translocation to the nuclei
Generation of the p65-GFP-expressing cell line and the
automated image analysis to quantify translocation of p65-GFP
is described elsewhere (Bartfeld et al., submitted). Briefly, SIB02
cells are AGS cells lentivirally transduced to express p65-GFP.
SIB02 cells, seeded in 96-well-plates, were inoculated with EPEC
strains at MOI 1:100, incubated for 3 h and subsequently
activated by 10 ng/ml TNFa. After an appropriate incubation
time, cells were fixed using 100% ice-cold methanol and stained
with Hoechst 33342 (2 mg/ml). Images of ,200 cells were
acquired using automated microscopy (Scan
‘R, Olympus) and
translocation of p65-GFP to the nucleus was subsequently
quantified using Scan
‘R image analysis software (Olympus) as
described (Bartfeld et. al., submitted). Cells with nuclear p65-GFP
above the defined threshold were termed ‘‘active’’ and the
percentage of active cells per well was calculated.
Nuclear cytoplasmic fractionation
HeLa cells (2.8610
6) were seeded in 10 cm plates. The next
day, the cells were infected with EPEC for 3.5 h as described. Cells
were then washed, treated with 20 ng/ml TNFa in DMEM for
30 min., washed with cold PBS, scrapped, transferred to
Eppendorf tubes and centrifuged (5 mins, 660 g, 4uC). Then,
the pellet was resuspended in 7 times the volume of Hypotonic
Lysis Buffer (HLB, 10mM HEPES pH 7.6, 0.1mM EDTA,
0.1 mM EGTA, 2mM DTT, 10mM KCl, 1mM PMSF,
0.75mM Sperimidine, 0.15mM Sperimide, 20mM PNPP, 1mM
okadaic acid and 5mg/ml protease inhibitor), incubated on ice for
15 mins and then 0.2% NP40 was added gently following gentle
mixing for several minutes. The lysate was then centrifuged
(5 mins, 2600 g, 4uC), the supernatant (cytoplasmic fraction) was
recovered and the pellet (nuclear fraction) was washed with HLB
once and then resuspended in 100 ml Nuclear Extraction Buffer
(NEB, 210 mM HEPES pH 7.6, 0.2 mM EDTA, 2 mM EGTA,
0.5 mM DTT, 25% Glycerol, 0.42 M NaCl, 20 mM glycero-
phosphate, 29 mM PNPP, 1 mM okadiac acid, 1 mM NaVO4,
5 mg/ml protease inhibitor, 0.75 mM Sperimidine, 0.15 mM
Sperimide). The nuclear lysets were then vortexed, mixed
vigorously (1400 rpm, 30 min., 4uC) and clarified (20,000 g,
10 min, 4uC). Protein concentrations were determined (BCA kit,
Sigma), adjusted and the extracts were used for western analysis
using anti-NF-kB p65 antibodies (Santa Cruz, SC372). The
quality of the fractionation was confirmed using tubulin as a
cytoplasmic marker and fibrillarin as a nuclear marker.
Expression and translocation of NleE-BlaM fusions
To determine translocation levels, overnight cultures of wild-
type EPEC containing plasmids expressing NleE-BlaM were
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were then washed and stained with CCF2 for 2.5 h as described
[26], washed in cDMEM, excited at 405 nm, and then emission at
465 nm and 535 nm was recorded (SPECTRAFluor, TECAN).
The amount of translocation was determined as described [26]. As
a negative control, we used EPEC expressing unfused BlaM
(Vector). To determine expression levels, the unattached bacteria
were harvested, washed, and lysed by repeated freezing and
thawing in PBS containing 1 mM EDTA, 1 mg/ml lysozyme, and
0.1% Triton-6100. The BlaM activity in the lysate was
determined using nitrocefin as substrate and the rate of product
accumulation per number of bacteria (OD 600) was determined as
described [25].
IL-8 expression
HeLa cells (7610
5) in 6 wells plates were inoculated with a
1:100 dilution in DMEM of bacteria grown overnight statically at
37uC (multiplicity of infection, MOI,1:100) and incubated for
3 h (5% CO2,3 7 uC). To terminate the infection and induce IL8
expression, the medium was replaced with fresh DMEM
supplemented with 2% FCS, 100ug/ul gentamicin and with or
without 10 ng/ml TNFa and incubated for additional 3 h. Cells
were than washed with 2 ml of cold TBS (20 mM Tris-HCl,
pH 7.4, 150 mM NaCl), scraped with 1 ml of cold TBS, collected
and centrifuged, (800 g, 2 min, 4uC). RNA was extracted using the
MasterPure Complete DNA and RNA Purification Kit (EPICEN-
TRE Biotechnologies) and used to synthesize cDNA with the
Verso cDNA kit (Thermo scientific). hHPRT transcript levels were
used to normalize total RNA levels in samples. Real time analysis
was than conducted using Absolute Blue QPCR SYBR Green
(Thermo scientific) in a real-time cycler (Rotor-Gene 6000,
Corbett).
Transfection of pCherry-nleE into HeLa cells and p65
staining
HeLa cells were transfected using ExGen500 (Fermentas), as
recommended by the manufacturer, with 1 mg of pMS2841
(pmCherry), pSC4144 or pSC4350 (pmCherry-nleEs) or were not
transfected. After 24 h, the medium was replaced with fresh
DMEM containing, or not containing, 10 ng/ml TNFa. After 1 h,
cells were fixed (3.7% PFA in PBS for 10 min and washed with
PBS), perforated (with 0.25% Triton-X100 in PBS for 10 min and
washed twice with PBS) and blocked (2% BSA in TBS) at 4uC for
16 h. Cells were then stained using anti-p65 (SC109, Cell
Signaling) antibodies (1:300 in TBS) overnight and further stained
with CY-488 goat anti-rabbit (Cell Signaling) (1:1000 in TBS) for
1 h. Slides were analyzed by fluorescent microscopy.
Supporting Information
Table S1 Strains. All strains are made in EPEC E2348/69.
Found at: doi:10.1371/journal.ppat.1000743.s001 (0.02 MB PDF)
Table S2 Plasmids
Found at: doi:10.1371/journal.ppat.1000743.s002 (0.02 MB PDF)
Table S3 Primers. F=forward, R=reverse.
Found at: doi:10.1371/journal.ppat.1000743.s003 (0.02 MB PDF)
Figure S1 Comparison between different NleE genes of different
EPEC and EHEC strains. The E2348 NleEIE6 is indicated as
E2348-NLEE2 and NleEIE2 as E2348-NLEE1). Other NleE
proteins are those of two EPEC strains (O111 B171 and O103
E22), two EHEC O157 strains (Sakai and EDL933) and Citrobacter
rodentium.
Found at: doi:10.1371/journal.ppat.1000743.s004 (1.58 MB
TIF)
Figure S2 NleE is involved in blocking IL8 secretion. HeLa cells
(8610
4 per well, seeded in 24-well plate) were infected for 3h with
different EPEC strains as indicated or remained uninfected (N/I).
After 3.5 h, supernatants were replaced with 300 ul DMEM, 2%
FCS, and 50 mg/ml gentamycin with or without 10 ng/ml TNFa.
After 16 h, 100 ml of cleared supernatant taken from each well was
used for IL-8 measurements using Human CXCL8/IL-8 Quanti-
kine immunoassay assay (R & D), according to the manufacturer’s
instructions. PBS and IL-8 were used as negative and positive
controls for the detection assay. The relative amounts of IL-8 are
shown. The experiment was done twice in duplicates and typical
results are shown. Standard errors are indicated by bars. In the
case of DescV (indicated by a vanishing colored bar), the signal was
above the upper limit of the detection levels. Untreated and
uninfected cells secreted ,300 units of IL-8, whereas TNFa
treatment induced a 10-fold increase in IL-8 secretion (,3000
units) (Fig. 4B). In contrast, pre-infection with wild-type EPEC or
with the DIE2 mutant (WTDIE2), reduced IL-8 secretion below the
detection levels, even upon TNFa treatment. Furthermore, the
TTSS escV mutant was completely deficient in blocking IL-8
secretion. In conclusion, EPEC strongly reduces IL-8 secretion by
a TTSS-dependent mechanism. Importantly, we found that the
DnleE or DnleEB mutants were strongly deficient in blocking IL-8
secretion but not as deficient as the TTSS mutant (escV). These
results show that (i) NleE is required for full inhibition of IL-8
secretion and (ii) other putative TTSS effector(s) might function in
parallel to NleE to inhibit IL-8 expression and/or secretion.
Found at: doi:10.1371/journal.ppat.1000743.s005 (1.62 MB TIF)
Figure S3 A mutant baring a deletion of nleBE is deficient in
repressing self-activated, or TNFa-induced, IL8 repression. HeLa
cells were infected with the indicated strains and analyzed as
described in Fig. 4B and 4C. To terminate the infection and
induce IL8 expression, the medium was replaced with fresh
DMEM supplemented with 2% FCS, 100ug/ul gentamicin and
with or without 10 ng/ml TNFa and incubated for additional 3 h.
Cells were than washed with 2 ml of cold TBS (20 mM Tris-HCl,
pH 7.4, 150 mM NaCl), scraped with 1 ml of cold TBS, collected
and centrifuged, (800 g, 2 min, 4uC). RNA was extracted using the
MasterPure Complete DNA and RNA Purification Kit (EPICEN-
TRE Biotechnologies) and used to synthesize cDNA with the
Verso cDNA kit (Thermo Scientific). hHPRT transcript levels
were used to normalize total RNA levels in samples. Real time
analysis was than conducted using Absolute Blue QPCR SYBR
Green (Thermo Scientific) in a real-time cycler (Rotor-Gene 6000,
Corbett). The amount of IL-8 mRNA in each strain is shown as a
percentage of the level relatively to the transcript levels in the
DescV mutant. The experiment was done twice in duplicates and
typical results are shown. Bars indicate standard errors.
Found at: doi:10.1371/journal.ppat.1000743.s006 (0.44 MB
TIF)
Figure S4 NleEIE2 is deficient in blocking TNF-induced
translocation of p65 to the nucleus. HeLa cells were transected
with plasmids expressing mCherry, mCherry-NleEIE2 or
mCherry-NleEIE6. The expressing cells were treated with TNFa
for 1 h, or remained untreated, after which they were fixed and
stained with anti-p65. The slides were analyzed by fluorescent
microscopy and the percentage of red cells (expressing mCherry or
mCherry fused to NleEIE6 or NleEIE2) containing nuclear p65 was
determined. The number of cells quantified is indicated and
standard errors are indicated by bars. The results show that while
NleEIE6 inhibited p65 translocation, NleEIE2 failed to do so.
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